Literature DB >> 25147005

Transplantation of tail skin to study allogeneic CD4 T cell responses in mice.

Mathias Schmaler1, Maria A S Broggi1, Simona W Rossi2.   

Abstract

The study of T cell responses and their consequences during allo-antigen recognition requires a model that enables one to distinguish between donor and host T cells, to easily monitor the graft, and to adapt the system in order to answer different immunological questions. Medawar and colleagues established allogeneic tail-skin transplantation in mice in 1955. Since then, the skin transplantation model has been continuously modified and adapted to answer specific questions. The use of tail-skin renders this model easy to score for graft rejection, requires neither extensive preparation nor deep anesthesia, is applicable to animals of all genetic background, discourages ischemic necrosis, and permits chemical and biological intervention. In general, both CD4(+) and CD8(+) allogeneic T cells are responsible for the rejection of allografts since they recognize mismatched major histocompatibility antigens from different mouse strains. Several models have been described for activating allogeneic T cells in skin-transplanted mice. The identification of major histocompatibility complex (MHC) class I and II molecules in different mouse strains including C57BL/6 mice was an important step toward understanding and studying T cell-mediated alloresponses. In the tail-skin transplantation model described here, a three-point mutation (I-A(bm12)) in the antigen-presenting groove of the MHC-class II (I-A(b)) molecule is sufficient to induce strong allogeneic CD4(+) T cell activation in C57BL/6 mice. Skin grafts from I-A(bm12) mice on C57BL/6 mice are rejected within 12-15 days, while syngeneic grafts are accepted for up to 100 days. The absence of T cells (CD3(-/-) and Rag2(-/-) mice) allows skin graft acceptance up to 100 days, which can be overcome by transferring 2 x 10(4) wild type or transgenic T cells. Adoptively transferred T cells proliferate and produce IFN-γ in I-A(bm12)-transplanted Rag2(-/-) mice.

Entities:  

Mesh:

Year:  2014        PMID: 25147005      PMCID: PMC4672937          DOI: 10.3791/51724

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  21 in total

1.  Cutting edge: perforin down-regulates CD4 and CD8 T cell-mediated immune responses to a transplanted organ.

Authors:  Anirban Bose; Yoshihiko Inoue; Kenneth E Kokko; Fadi G Lakkis
Journal:  J Immunol       Date:  2003-02-15       Impact factor: 5.422

2.  B6.C-H-2bm12. A new H-2 mutation in the I region in the mouse.

Authors:  I F McKenzie; G M Morgan; M S Sandrin; M M Michaelides; R W Melvold; H I Kohn
Journal:  J Exp Med       Date:  1979-12-01       Impact factor: 14.307

3.  Skin allograft rejection.

Authors:  Hugh I McFarland; Amy S Rosenberg
Journal:  Curr Protoc Immunol       Date:  2009-02

4.  IL-4 deficiency prevents eosinophilic rejection and uncovers a role for neutrophils in the rejection of MHC class II disparate skin grafts.

Authors:  Murielle Surquin; Alain Le Moine; Véronique Flamand; Katia Rombaut; François-Xavier Demoor; Isabelle Salmon; Michel Goldman; Daniel Abramowicz
Journal:  Transplantation       Date:  2005-11-27       Impact factor: 4.939

5.  Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways.

Authors:  C P Larsen; E T Elwood; D Z Alexander; S C Ritchie; R Hendrix; C Tucker-Burden; H R Cho; A Aruffo; D Hollenbaugh; P S Linsley; K J Winn; T C Pearson
Journal:  Nature       Date:  1996-05-30       Impact factor: 49.962

6.  Interferon-gamma is necessary for initiating the acute rejection of major histocompatibility complex class II-disparate skin allografts.

Authors:  G H Ring; S Saleem; Z Dai; A T Hassan; B T Konieczny; F K Baddoura; F G Lakkis
Journal:  Transplantation       Date:  1999-05-27       Impact factor: 4.939

7.  Disturbed MHC regulation in the IFN-gamma knockout mouse. Evidence for three states of MHC expression with distinct roles for IFN-gamma.

Authors:  N Goes; T Sims; J Urmson; D Vincent; V Ramassar; P F Halloran
Journal:  J Immunol       Date:  1995-11-15       Impact factor: 5.422

8.  Provocation of skin graft rejection across murine class II differences by non--bone-marrow-derived cells.

Authors:  P M Stuart; B Beck-Maier; R W Melvold
Journal:  Transplantation       Date:  1984-04       Impact factor: 4.939

9.  Delayed rejection of MHC class II-disparate skin allografts in mice treated with farnesyltransferase inhibitors.

Authors:  Alison E Gaylo; Kathleen S Laux; Erika J Batzel; Morgan E Berg; Kenneth A Field
Journal:  Transpl Immunol       Date:  2008-10-18       Impact factor: 1.708

10.  The contribution of mutant amino acids to alloantigenicity.

Authors:  J Bill; F Ronchese; R N Germain; E Palmer
Journal:  J Exp Med       Date:  1989-09-01       Impact factor: 14.307

View more
  4 in total

1.  Cutting Edge: Allograft Rejection Is Associated with Weak T Cell Responses to Many Different Graft Leukocyte-Derived Peptides.

Authors:  Adam L Burrack; Deepali Malhotra; Thamotharampillai Dileepan; Kevin C Osum; Linnea A Swanson; Brian T Fife; Marc K Jenkins
Journal:  J Immunol       Date:  2017-12-18       Impact factor: 5.422

2.  Murine Full-thickness Skin Transplantation.

Authors:  Chih-Hsien Cheng; Chen-Fang Lee; Madeline Fryer; Georg J Furtmüller; Byoungchol Oh; Jonathan D Powell; Gerald Brandacher
Journal:  J Vis Exp       Date:  2017-01-02       Impact factor: 1.355

3.  Optimizing PLG nanoparticle-peptide delivery platforms for transplantation tolerance using an allogeneic skin transplant model.

Authors:  Sahil Shah; Saeed Daneshmandi; Kevin R Hughes; Shuangjin Yu; Angela M Bedoya; Lonnie D Shea; Xunrong Luo
Journal:  Biomaterials       Date:  2019-05-01       Impact factor: 12.479

4.  Skin Transplantation and Lymphoid Organ Analysis in Mice.

Authors:  Julie Ruer-Laventie; Rajesh Jayachandran; Mathias Schmaler; Simona W Rossi; Jean Pieters
Journal:  Bio Protoc       Date:  2020-02-20
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.